AK Medical Holdings Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Zhijiang Li
Chief executive officer
CN¥1.1m
Total compensation
| CEO salary percentage | 74.9% |
| CEO tenure | 9.5yrs |
| CEO ownership | 45.0% |
| Management average tenure | 4.1yrs |
| Board average tenure | 8.9yrs |
Recent management updates
Recent updates
We Think AK Medical Holdings (HKG:1789) Can Stay On Top Of Its Debt
Dec 13
AK Medical Holdings Limited (HKG:1789) Not Flying Under The Radar
Nov 18AK Medical Holdings Limited's (HKG:1789) Intrinsic Value Is Potentially 92% Above Its Share Price
Aug 30Why We're Not Concerned Yet About AK Medical Holdings Limited's (HKG:1789) 25% Share Price Plunge
Jun 20It's Unlikely That Shareholders Will Increase AK Medical Holdings Limited's (HKG:1789) Compensation By Much This Year
Jun 11Returns On Capital At AK Medical Holdings (HKG:1789) Paint A Concerning Picture
May 27We Think AK Medical Holdings (HKG:1789) Can Stay On Top Of Its Debt
May 08Investors Appear Satisfied With AK Medical Holdings Limited's (HKG:1789) Prospects
Apr 21AK Medical Holdings Limited (HKG:1789) Analysts Are Reducing Their Forecasts For This Year
Apr 01AK Medical Holdings' (HKG:1789) Returns On Capital Not Reflecting Well On The Business
Jan 22Shareholders Should Be Pleased With AK Medical Holdings Limited's (HKG:1789) Price
Jan 04AK Medical Holdings (HKG:1789) Seems To Use Debt Rather Sparingly
Dec 12A Look At The Fair Value Of AK Medical Holdings Limited (HKG:1789)
Nov 09AK Medical Holdings (HKG:1789) Could Be Struggling To Allocate Capital
Sep 20AK Medical Holdings (HKG:1789) Could Easily Take On More Debt
Sep 03Investors Could Be Concerned With AK Medical Holdings' (HKG:1789) Returns On Capital
Jun 07Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)
May 18Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)
Feb 13Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)
Nov 10Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)
Sep 29Be Wary Of AK Medical Holdings (HKG:1789) And Its Returns On Capital
Aug 04Are Investors Undervaluing AK Medical Holdings Limited (HKG:1789) By 44%?
Jun 25There Are Reasons To Feel Uneasy About AK Medical Holdings' (HKG:1789) Returns On Capital
Apr 11Capital Allocation Trends At AK Medical Holdings (HKG:1789) Aren't Ideal
Oct 08Estimating The Intrinsic Value Of AK Medical Holdings Limited (HKG:1789)
Sep 20Analysts Are More Bearish On AK Medical Holdings Limited (HKG:1789) Than They Used To Be
Jul 27I Built A List Of Growing Companies And AK Medical Holdings (HKG:1789) Made The Cut
Jul 19AK Medical Holdings Limited (HKG:1789) Shares Could Be 39% Below Their Intrinsic Value Estimate
Jun 16The Returns On Capital At AK Medical Holdings (HKG:1789) Don't Inspire Confidence
Jun 01CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥189m |
| Mar 31 2024 | n/a | n/a | CN¥185m |
| Dec 31 2023 | CN¥1m | CN¥814k | CN¥182m |
| Sep 30 2023 | n/a | n/a | CN¥197m |
| Jun 30 2023 | n/a | n/a | CN¥211m |
| Mar 31 2023 | n/a | n/a | CN¥208m |
| Dec 31 2022 | CN¥972k | CN¥806k | CN¥205m |
| Sep 30 2022 | n/a | n/a | CN¥156m |
| Jun 30 2022 | n/a | n/a | CN¥107m |
| Mar 31 2022 | n/a | n/a | CN¥100m |
| Dec 31 2021 | CN¥913k | CN¥800k | CN¥93m |
| Sep 30 2021 | n/a | n/a | CN¥178m |
| Jun 30 2021 | n/a | n/a | CN¥263m |
| Mar 31 2021 | n/a | n/a | CN¥288m |
| Dec 31 2020 | CN¥524k | CN¥430k | CN¥314m |
| Sep 30 2020 | n/a | n/a | CN¥307m |
| Jun 30 2020 | n/a | n/a | CN¥300m |
| Mar 31 2020 | n/a | n/a | CN¥284m |
| Dec 31 2019 | CN¥1m | CN¥779k | CN¥267m |
| Sep 30 2019 | n/a | n/a | CN¥235m |
| Jun 30 2019 | n/a | n/a | CN¥203m |
| Mar 31 2019 | n/a | n/a | CN¥174m |
| Dec 31 2018 | CN¥1m | CN¥764k | CN¥145m |
Compensation vs Market: Zhijiang's total compensation ($USD148.92K) is below average for companies of similar size in the Hong Kong market ($USD472.45K).
Compensation vs Earnings: Zhijiang's compensation has been consistent with company performance over the past year.
CEO
Zhijiang Li (56 yo)
9.5yrs
Tenure
CN¥1,087,000
Compensation
Mr. Zhijiang Li serves as Chairman and Chief Executive Officer at AK Medical Holdings Limited. Mr. Li is responsible for the overall strategic planning and development of at AK Medical Holdings Limited. Mr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | no data | CN¥1.09m | 45% HK$ 2.3b | |
| Senior VP & Executive Director | 8.8yrs | CN¥193.00k | 0.90% HK$ 47.0m | |
| Senior VP & Executive Director | 8.8yrs | CN¥1.19m | 5.24% HK$ 272.9m | |
| Executive Director | no data | CN¥1.57m | 0.19% HK$ 9.9m | |
| Chief Financial Officer | 4.1yrs | no data | no data | |
| Vice President of Human Resources | 3.7yrs | no data | no data | |
| Company Secretary | less than a year | no data | no data |
4.1yrs
Average Tenure
53yo
Average Age
Experienced Management: 1789's management team is considered experienced (4.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 9.5yrs | CN¥1.09m | 45% HK$ 2.3b | |
| Senior VP & Executive Director | 9.5yrs | CN¥193.00k | 0.90% HK$ 47.0m | |
| Senior VP & Executive Director | 9.5yrs | CN¥1.19m | 5.24% HK$ 272.9m | |
| Executive Director | 8.9yrs | CN¥1.57m | 0.19% HK$ 9.9m | |
| Non-Executive Director | 8.9yrs | no data | no data | |
| Independent Non-Executive Director | 7.2yrs | CN¥178.00k | no data | |
| Independent Non-Executive Director | 7.2yrs | CN¥178.00k | no data | |
| Independent Non-Executive Director | less than a year | no data | no data |
8.9yrs
Average Tenure
56yo
Average Age
Experienced Board: 1789's board of directors are considered experienced (8.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 05:10 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
AK Medical Holdings Limited is covered by 10 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yichi Zhang | China International Capital Corporation Limited |
| null null | CMB International Securities Limited |
| Yu Wu | CMB International Securities Limited |